DE69333377D1 - Neuartige marker maligner zelltypen in der inneren nukleären matrix - Google Patents
Neuartige marker maligner zelltypen in der inneren nukleären matrixInfo
- Publication number
- DE69333377D1 DE69333377D1 DE69333377T DE69333377T DE69333377D1 DE 69333377 D1 DE69333377 D1 DE 69333377D1 DE 69333377 T DE69333377 T DE 69333377T DE 69333377 T DE69333377 T DE 69333377T DE 69333377 D1 DE69333377 D1 DE 69333377D1
- Authority
- DE
- Germany
- Prior art keywords
- cell types
- nuclear matrix
- maligner
- innovative
- marker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90170192A | 1992-06-22 | 1992-06-22 | |
PCT/US1993/006160 WO1994000573A1 (en) | 1992-06-22 | 1993-06-21 | Novel malignant cell type markers of the interior nuclear matrix |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69333377D1 true DE69333377D1 (de) | 2004-02-12 |
DE69333377T2 DE69333377T2 (de) | 2004-10-21 |
Family
ID=25414663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69333377T Expired - Lifetime DE69333377T2 (de) | 1992-06-22 | 1993-06-21 | Neuartige marker maligner zelltypen in der inneren nukleären matrix |
Country Status (9)
Country | Link |
---|---|
US (5) | US5783403A (de) |
EP (1) | EP0647270B1 (de) |
JP (1) | JPH07509602A (de) |
AT (1) | ATE257513T1 (de) |
AU (1) | AU681855B2 (de) |
CA (1) | CA2138807A1 (de) |
DE (1) | DE69333377T2 (de) |
ES (1) | ES2214476T3 (de) |
WO (1) | WO1994000573A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE191567T1 (de) * | 1991-10-31 | 2000-04-15 | Matritech Inc | Bestimmung von nukleären matrixproteinen in flüssigkeiten |
WO1994018222A1 (en) * | 1993-02-09 | 1994-08-18 | The Johns Hopkins University School Of Medicine | Nuclear matrix proteins |
US6280956B1 (en) | 1995-11-03 | 2001-08-28 | University Of Pittsburgh | Antibodies to bladder cancer nuclear matrix proteins and their use |
WO1997016206A1 (en) * | 1995-11-03 | 1997-05-09 | Getzenberg Robert H | Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
US5914238A (en) * | 1996-06-05 | 1999-06-22 | Matritech, Inc. | Materials and methods for detection of breast cancer |
US5858683A (en) | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6232443B1 (en) * | 1997-04-08 | 2001-05-15 | University Of Pittsburgh | Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
US7021122B1 (en) | 1998-03-19 | 2006-04-04 | Orgenics Biosensors Ltd. | Device for the determination of blood clotting by capacitance or resistance |
US6287790B1 (en) * | 1998-11-30 | 2001-09-11 | The Regents Of The University Of California | Utilization of nuclear structural proteins for targeted therapy and detection of proliferative and differentiation disorders |
EP1826569A1 (de) | 1999-05-17 | 2007-08-29 | Cytyc Corporation | Identifizierung von Material aus Brustgängen |
US6617432B1 (en) | 1999-10-15 | 2003-09-09 | University Of Pittsburgh | Nuclear matrix proteins polynucleotide sequences encoding them and their use |
US20030228640A1 (en) | 1999-10-15 | 2003-12-11 | University Of Pittsburgh | Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
SE523665C2 (sv) * | 2002-09-20 | 2004-05-11 | Volvo Technology Corp | Bränslecell och bränslecellsstack |
US20070154966A1 (en) * | 2003-12-29 | 2007-07-05 | Ronit Sagi-Eisenberg | Assay for the detection of rapamycin and rapamycin analogs |
DE102004052729A1 (de) * | 2004-10-30 | 2006-05-04 | Roche Diagnostics Gmbh | Immunkomplex-spezifsicher Antikörper zur Reduktion des Nullwerts beim Nachweis von Antigen-spezifisch gebundenen Antikörpern einer bestimmten Immunglobulinklasse in Array-Testformaten |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273877A (en) * | 1985-12-24 | 1993-12-28 | Massachusetts Institute Of Technology | Non-histological cell type determination |
US4882268A (en) * | 1985-12-24 | 1989-11-21 | Massachusetts Institute Of Technology | Method for determining tissue of origin and degree of malignancy of tumor cells |
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
US5098890A (en) * | 1988-11-07 | 1992-03-24 | Temple University-Of The Commonwealth System Of Higher Education | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
AU7974791A (en) * | 1990-05-01 | 1991-11-27 | Isis Pharmaceuticals, Inc. | Identification of novel drugs and reagents |
ATE191567T1 (de) * | 1991-10-31 | 2000-04-15 | Matritech Inc | Bestimmung von nukleären matrixproteinen in flüssigkeiten |
-
1993
- 1993-06-21 EP EP93916829A patent/EP0647270B1/de not_active Expired - Lifetime
- 1993-06-21 JP JP6502629A patent/JPH07509602A/ja active Pending
- 1993-06-21 ES ES93916829T patent/ES2214476T3/es not_active Expired - Lifetime
- 1993-06-21 WO PCT/US1993/006160 patent/WO1994000573A1/en active IP Right Grant
- 1993-06-21 AT AT93916829T patent/ATE257513T1/de not_active IP Right Cessation
- 1993-06-21 AU AU46550/93A patent/AU681855B2/en not_active Expired
- 1993-06-21 CA CA002138807A patent/CA2138807A1/en not_active Abandoned
- 1993-06-21 DE DE69333377T patent/DE69333377T2/de not_active Expired - Lifetime
-
1994
- 1994-02-14 US US08/195,487 patent/US5783403A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/470,950 patent/US5698439A/en not_active Expired - Lifetime
- 1995-06-06 US US08/466,390 patent/US5686562A/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,781 patent/US5780596A/en not_active Expired - Lifetime
- 1995-06-07 US US08/483,924 patent/US5882876A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5698439A (en) | 1997-12-16 |
CA2138807A1 (en) | 1994-01-06 |
ES2214476T3 (es) | 2004-09-16 |
WO1994000573A1 (en) | 1994-01-06 |
JPH07509602A (ja) | 1995-10-26 |
ATE257513T1 (de) | 2004-01-15 |
AU681855B2 (en) | 1997-09-11 |
US5783403A (en) | 1998-07-21 |
EP0647270B1 (de) | 2004-01-07 |
AU4655093A (en) | 1994-01-24 |
US5686562A (en) | 1997-11-11 |
US5780596A (en) | 1998-07-14 |
DE69333377T2 (de) | 2004-10-21 |
EP0647270A1 (de) | 1995-04-12 |
US5882876A (en) | 1999-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69333377T2 (de) | Neuartige marker maligner zelltypen in der inneren nukleären matrix | |
Sarkar et al. | Receptors for human gamma interferon: binding and crosslinking of 125I-labeled recombinant human gamma interferon to receptors on WISH cells. | |
Hock et al. | Isolation of the human placenta receptor for epidermal growth factor-urogastrone | |
BG100771A (en) | Hematopoeic protein and ways and methods for its preparation | |
ATE352618T1 (de) | Rezeptor 5, der eine für den zelltod verantwortliche domäne enthält | |
AR006188A1 (es) | "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion". | |
DK2289D0 (da) | Monoklonale antistoffer samt deres fremstilling og anvendelse | |
DE69717664D1 (de) | Protein e25a, methoden zu dessen herstellung und anwendung | |
AU1724795A (en) | Human tissue inhibitor of metalloproteinase-4 | |
ATE314462T1 (de) | Verfahren zur transformation dendritischer zellen und aktivierung von t zellen | |
AR008847A1 (es) | Construcciones de acidos nucleicos para la expresion regulada de un transgen en una celula hospedante para uso en la terapia fenica y lamanipulacion genetica, una celula aislada que los comprende y una composicion farmaceutica | |
ES2078979T3 (es) | Mutantes del inhibidor del activador de plasminogeno humano 1 (pai-1), su preparacion y uso. | |
EP0566571A4 (de) | Diagnose von krebs-metastasen durch das mts-1 gen. | |
Rosen et al. | Human placenta contains an epithelial scatter protein | |
NO984491D0 (no) | SCF-analogpreparater og fremgangsmÕte for fremstilling av disse | |
Nakai et al. | The transformation-sensitive heat shock protein (hsp47) binds specifically to Fetuin | |
EP1655382A3 (de) | Dickdarm spezifisches Gen und Protein | |
Shih et al. | Identification of neighbor relationships among proteins in the 30 S ribosome: intermolecular cross-linkage of three proteins induced by tetranitromethane | |
ATE265533T1 (de) | Saeugetierchemokine | |
Baszczynski et al. | Regulation of gene expression in corn (Zea mays L.) by heat shock. II. In vitro analysis of RNAs from heat-shocked seedlings | |
CA2067797A1 (en) | Production and use of human nm23 protein and antibodies therefor | |
Tegtmeyer et al. | Partial purification of SV40 A protein and a related cellular protein from permissive cells | |
NO985742D0 (no) | IL-1/TNF-<alfa>-aktivert kinase (ITAK) og fremgangsmÕter for fremstilling og anvendelse av denne | |
SCHAUDIES et al. | Intracellular modification of 125I-labeled epidermal growth factor by normal human foreskin fibroblasts | |
ES2045004T3 (es) | Procedimiento para la preparacion de proteinas extra\as en estreptomicetos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: MATRITECH, INC. (N.D.GES.D. STAATES DELAWARE),, US |